Biocev - Czelo 30 May 2012
-
Upload
ablueangelfalls -
Category
Documents
-
view
215 -
download
0
Transcript of Biocev - Czelo 30 May 2012
-
7/31/2019 Biocev - Czelo 30 May 2012
1/12
Biotechnology and Biomedicine Centre
of the Academy of Sciences and Charles University in Vestec
www.biocev.eu
INTRODUCING BIOCEV
Biotechnology and Biomedicine Centre
of the Academy of Sciences and CharlesUniversity in Vestec
-
7/31/2019 Biocev - Czelo 30 May 2012
2/12
www.biocev.eu
BASIC FACTS
400 researchers
200 students
5 research programmes
54 research teams
5 state of the art core facilities
Tech transfer department
Integration into the EuropeanResearch Area
-
7/31/2019 Biocev - Czelo 30 May 2012
3/12
www.biocev.eu
WHO IS BIOCEV
Applicant/recipient
Institute of Molecular Genetics of the ASCR, v. v. i
PartnersCharles University in Prague
Institute of Biotechnology of the ASCR, v. v. i.Institute of Physiology of the ASCR, v. v. i.
Institute of Microbiology of the ASCR, v. v. i.
Institute of Experimental Medicine of the ASCR, v. v. i.
Institute of Macromolecular Chemistry of the ASCR, v. v. i.
-
7/31/2019 Biocev - Czelo 30 May 2012
4/12
www.biocev.eu
LOCATION
The centre will be built in the industrial part of CentralBohemian village Vestec, in close vicinity of several biotechcompanies
Total surface area of the modern laboratories - 25,500 sqm
Excellent accessibility by both public and private transport
Favourable location - close to a major Academy of Sciences
biomedical campus
-
7/31/2019 Biocev - Czelo 30 May 2012
5/12
www.biocev.eu
FUNDING
Funded by European RegionalDevelopment Fund (through OP RDI)
Estimated total project cost: 120 mil.EUR
EU Funding: 80 mil. EUR
-
7/31/2019 Biocev - Czelo 30 May 2012
6/12
www.biocev.eu
PRINCIPLES
Three pillars of the knowledge triangle:
Research - synergic research programme, unique top-qualitytechnology in central laboratories
Education - development of new, tailor-made study programmes,training of business employees in advanced biotechnologymethods
Transfer of research results to practice - intensive collaborationwith the commercial sphere
-
7/31/2019 Biocev - Czelo 30 May 2012
7/12
www.biocev.eu
RESEARCH
Research Programme
Functional GenomicsCellular Biology and Virology
Structural Biology and Protein Engineering
Biomaterials and Tissue Engineering
Development of Therapeutic and Diagnostic ProceduresCore Facilities
Czech Centre for Phenogenomics
Imaging Methods
OMICSCentre of Molecular Structure
Cryotechnologies
-
7/31/2019 Biocev - Czelo 30 May 2012
8/12
www.biocev.eu
EUROPEAN RESEARCH AREA
INTEGRATION
BIOCEV is currently a member of three European
infrastructures Infrafrontier, Euro-BioImaging andInstruct
All these are part of ESFRI
Membership in Elixir is currently under negotiations
Integration of these projects under one roof putsBIOCEV into a special position in the context of theCzech research institutions
-
7/31/2019 Biocev - Czelo 30 May 2012
9/12
www.biocev.eu
INFRAFRONTIER
Infrafrontier is the European infrastructure for
Phenotyping and Archiving of Model MammalianGenomes
The Goal: to define the function of all mouse genes andin this way model the gene functions in man
Infrafrontier brings together partners from twelveEuropean countries and Canada
Scientific partners are the leading research facilities in
the field of systemic phenotyping, archiving anddistribution of mouse models
-
7/31/2019 Biocev - Czelo 30 May 2012
10/12
www.biocev.eu
EURO-BIOIMAGING
Mission:
access to state-of-the-art imagingtechnologies in biomedical sciences
service & training & data
foster cooperation & innovation
share expertise & best practice
Preparatory phase 2010 2013Goal: To develop a construction and operation plan of alarge European RI in biological and medical imaging.
-
7/31/2019 Biocev - Czelo 30 May 2012
11/12
www.biocev.eu
CURRENT SCHEDULE
31 October 2011 BIOCEV approved by the EuropeanCommission
31 January 2012 BIOCEV approved on the national level (eligiblefor the European funding)
1Q 2012 launch of the recruitment process for researchers
Summer 2012 commencement of technology and equipmentpurchase
April 2013 November 2014 construction phase
End of 2014 planned start of the trial operation of BIOCEV
2016 2020 the sustainability phase of the new centre
-
7/31/2019 Biocev - Czelo 30 May 2012
12/12
www.biocev.eu
CONTACTS
Institute of Molecular Genetics of the ASCR, v. v. i. - DivisionBIOCEV
Nad Safinou II 366
252 42 Vestec, Czech Republic
Tel.: +420 226 201 526, +420 774 798 102
E-mail: [email protected]
For Applicant /Recipient Scientific Coordinator
Prof. Vaclav Horejsi Prof. Vaclav PacesE-mail: [email protected] E-mail: [email protected]